tiprankstipranks
Jazz Pharmaceuticals reports Q1 non-GAAP EPS $2.68, consensus $4.18
PremiumThe FlyJazz Pharmaceuticals reports Q1 non-GAAP EPS $2.68, consensus $4.18
3d ago
Baird starts Praxis Precision at Outperform on ulixacaltamide’s potential
PremiumThe Fly
Baird starts Praxis Precision at Outperform on ulixacaltamide’s potential
4d ago
JAZZ Earnings this Week: How Will it Perform?
PremiumPre-Earnings
JAZZ Earnings this Week: How Will it Perform?
6d ago
Avadel Pharmaceuticals price target raised to $22 from $20 at Needham
PremiumThe FlyAvadel Pharmaceuticals price target raised to $22 from $20 at Needham
2M ago
Avadel Pharmaceuticals price target raised to $22 from $20 at Craig-Hallum
PremiumThe Fly
Avadel Pharmaceuticals price target raised to $22 from $20 at Craig-Hallum
2M ago
Avadel Pharmaceuticals price target raised to $29 from $27 at Oppenheimer
PremiumThe Fly
Avadel Pharmaceuticals price target raised to $29 from $27 at Oppenheimer
2M ago
Jazz Pharmaceuticals price target lowered to $220 from $225 at Needham
PremiumThe FlyJazz Pharmaceuticals price target lowered to $220 from $225 at Needham
2M ago
Jazz Pharmaceuticals price target lowered to $173 from $184 at BofA
PremiumThe Fly
Jazz Pharmaceuticals price target lowered to $173 from $184 at BofA
2M ago
Jazz Pharmaceuticals Announces Full Year and Fourth Quarter 2023 Financial Results and Provides 2024 Financial Guidance
PremiumPress Releases
Jazz Pharmaceuticals Announces Full Year and Fourth Quarter 2023 Financial Results and Provides 2024 Financial Guidance
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100